← FDA Drug Approvals (Drugs@FDA)
RIVAROXABAN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2026-03-02
Drug application
- FDA Application #
ANDA218427- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RIVAROXABAN
- Generic name
- Rivaroxaban
- Active ingredients
- RIVAROXABAN
- Dosage form
- FOR SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- APOTEX
- First approval
- 2026-03-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown